The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement
NCT07409285 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-02-13
Summary
Post-market registry for post-market surveillance, as part of the post-market plan, for the HighLife transcatheter, transseptal, mitral valve replacement system in a real world commercial setting.
Conditions
- Mitral Regurgitation
Sponsors & Collaborators
-
HighLife SAS
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-14
- Primary Completion
- 2029-04-15
- Completion
- 2031-04-15
Countries
- Germany
Study Locations
More Related Trials
-
HeartMate 3™ CE Mark Clinical Investigation Plan
NCT02170363 ·Status: COMPLETED ·Phase: NA
-
Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
NCT03271762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Belgian Mitraclip Registry
NCT02506387 ·Status: COMPLETED
-
BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction
NCT02876042 ·Status: UNKNOWN
-
HeartMate 3 ELEVATE™ Registry
NCT02497950 ·Status: COMPLETED
-
Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation
NCT01740583 ·Status: UNKNOWN ·Phase: NA
-
Edwards PASCAL Transcatheter Valve Repair System Registry
NCT04443218 ·Status: COMPLETED
-
BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature
NCT00983190 ·Status: COMPLETED ·Phase: NA
-
MitraClip® Registry
NCT02033811 ·Status: RECRUITING
-
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00572091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation
NCT01920698 ·Status: COMPLETED ·Phase: NA
-
MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study
NCT02948231 ·Status: COMPLETED ·Phase: NA
-
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602 ·Status: RECRUITING
-
Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical Practice
NCT02060682 ·Status: COMPLETED
-
Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
NCT05610566 ·Status: RECRUITING ·Phase: NA
-
Mitral Regurgitation Treatment in Advanced Heart Failure
NCT05292716 ·Status: RECRUITING ·Phase: NA
-
Percutaneous Mitral Valve Intervention: Predicting Improvements in Left Ventricular Performance
NCT04156295 ·Status: COMPLETED
-
Munich Transcatheter Mitral Valve Safety and Effectiveness
NCT05871983 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
NCT03714412 ·Status: WITHDRAWN ·Phase: NA
-
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
NCT03339115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease
NCT00677638 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00568230 ·Status: COMPLETED ·Phase: PHASE1
-
Cardioband With Transfemoral Delivery System
NCT01841554 ·Status: COMPLETED ·Phase: NA
-
MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR
NCT03705312 ·Status: UNKNOWN ·Phase: NA
-
CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study
NCT02722551 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2